graft-versus-host disease
ICD-10: T86.0MeSH: D006086ORPHA: 398122 Treatments Available
Overview
medical condition
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| ruxolitinib Orphan | Oral tablet, 5mg, 10mg, 15mg, 20mg, 25mg; Topical cream 1.5% | FDA Approved | 11 | 7d |
| belumosudil Orphan | Oral tablet, 200mg | FDA Approved | 2 | 10d |
Clinical Presentation
Signs and symptoms associated with graft-versus-host disease, sourced from HPO and Orphanet clinical annotations.
Inflammatory abnormality of the skinOral ulcerDiarrheaRecurrent infectionsElevated circulating hepatic transaminase concentrationStomatitisMaculopapular exanthemaSkin erosionChronic hepatitisIrritabilityJaundiceArthritisHepatosplenomegalyTachycardiaVomitingNauseaAbdominal painPneumoniaPulmonary infiltratesHyperbilirubinemiaLimited elbow movementElevated circulating alkaline phosphatase concentrationSkeletal muscle atrophyGastrointestinal inflammationLimited shoulder movementHemophagocytosisRecurrent gastroenteritisCutaneous sclerotic plaqueLichenoid skin lesionScaling skinInflammatory abnormality of the eyeFasciitisMyositisAcute hepatitisTrismusDecreased lacrimationFailure to thriveLymphadenopathyStiff interphalangeal jointsDupuytren contractureLipodystrophy
Classification & Codes
ICD-10 Code
T86.0MeSH Code
D006086Orphanet Code
ORPHA:39812graft-versus-host disease
| ICD-10 | T86.0 |
| MeSH | D006086 |
| Orphanet | ORPHA:39812 |
| Treatments | 2 drug(s) |
| Symptoms on record | 41 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO